Noninvasive, high-resolution MRI has shown its efficacy in the visualization of carotid atherosclerotic plaque characteristics. MRI is the only noninvasive option for thin plaque cap, active inflammation, fissured/injured plaque and intraplaque hemorrhage, is also useful in monitoring the response after statin therapy, and has the potential to image a coronary plaque and to determine its composition. New contrast agents and targeted molecular imaging open a window for MRI detection of thrombi and assessment of atherosclerotic activity and plaque vulnerability. Currently, multidetector CT is capable of the noninvasive detection of coronary stenosis and coronary calcifications. High resolution CT may be beneficial in the detection of noncalcified vulnerable coronary plaques, and more reliable with the use of newer high-speed volume CT scanners. (Korean Circulation J 2005 ; 35 : 1-14) KEY WORDS：Atherosclerosis；Tomography, spiral computed；Magnetic resonance imaging.
Introduction
Conventional angiography has been regarded as the gold standard technique for the detection and diagnosis of arterial stenosis and occlusion. Recently, noninvasive techniques have advanced very rapidly. Fast multidetector-row CT (MDCT) and MRI enable rapid screening of the whole body vascular tree for atherosclerosis. These imaging modalities demonstrate an angiographic display of the vasculature using three-dimensional image reconstruction techniques. [1] [2] [3] [4] CT and MRI also provide cross-sectional images of atherosclerotic vessels. 1)2)5) High-resolution CT and unique tissue contrast of MRI, combined with contrast agent application, may be useful in the characterization of atherosclerotic plaques. It is very important to detect coronary and carotid atherosclerosis before the fatal outcomes of the process appear clinically.
The concept of 'vulnerable plaque' implies that detection of unstable plaques is important in the prevention of future cardiovascular events, because vulnerable plaques may rupture and cause sudden arterial occlusion or distal embolization.
Naghavi et al. 6) proposed criteria for defining a vulnerable plaque based on the study of culprit plaques. In their proposal, the major criteria for vulnerable plaque were active inflammation, a thin cap with a large lipid core, endothelial denudation with superficial platelet aggregation, fissured plaque and stenosis >90%, and the minor criteria were a superficial calcified nodule, glistening yellow on angioscopy, intraplaque hemorrhage, endothelial dysfunction and outward remodeling.
Therefore, we were urged to find ideal noninvasive methods for atherosclerosis imaging. In this context, MDCT and MRI are most suited for this purpose.
For the detection of most major and minor criteria for plaque vulnerability, MRI and MDCT are noninvasive options.
MRI is the only noninvasive option for a thin plaque cap, active inflammation, fissured/injured plaques and an intraplaque hemorrhage. 6) MDCT and MRI are very rapidly evolving, and the future applications of these techniques are promising.
The resultant, timely and appropriate intervention of the atherosclerotic process may benefit patients by stabilizing atherosclerotic plaques or restoring the luminal diameter by angioplasty/stenting. High resolution and contrast of the images are achieved by high frequency transducers (7-13 MHz) and recent developments in imaging techniques, such as tissue harmonic US.
The intimomedial thickness is easily measurable by US.
However, US has limitations in characterizing the plaque. US has limited anatomical coverage of the internal carotid artery and is more operator-dependent than other techniques. (Fig. 1-5 ). [10] [11] [12] Fibrocellular components and loose connective tissue show modestly high signal intensities (SI) on T2WI (Fig. 1 ).
MRI of Atherosclerosis
8)
The lipid core typically shows low SI on T2WI and high SI on T1WI. Hemorrhagic components or thrombi are of variable SI on T2WI (low SI, mostly) and high SI on T1WI with fat saturation (Fig. 2) . Infrequently, hydrophilic necrosis shows very high SI on T2WI and low SI on T1WI ( 
MRI classification and characterization of atherosclerotic lesions
According to the study of Cai et al, 13) in vivo high-resolu- 
Evaluation of fibrous cap
The TOF technique can show the fibrous cap of the plaque as a low signal band along the plaque surface (Fig. 2, 3 ).
Multisequence MRI can accurately characterize the in vivo state of the fibrous cap. Hatsukami et al. 10) first described the use of the TOF sequence for fibrous cap imaging in vivo. 
Intraplaque hemorrhage
High SI in the plaque may suggest a focal area of fresh hemorrhage on TOF images (Fig. 2) . [16] [17] [18] A B detected using the TFE sequence, with high interobserver agreement (Kappa=0.73).
Gd-DTPA-enhanced imaging
Gd-DTPA-enhanced MRI may differentiate necrotic or lipid-rich components from fibrous components, as the former do not show enhancement, but the latter do (Fig. 4) . 19) Enhancement after injection of a conventional contrast agent, Gd-DTPA, indicates increased vascularity in the plaque.
Paradoxically, increased vascularity may mean an increased degree of inflammation and ongoing active atherosclerosis.
Plaques with increased vascularity are subject to increased risk of an intraplaque hemorrhage. According to Yuan et al., 19) there were statistically significant differences in the mean intensity change between tissues before and after contrast injection, with the largest increase for the fibrous tissue (79.5%) and the smallest for a necrotic core (28.6%). Additionally, histological analysis showed that a subset of fibrous regions, rich in plaque neovascularization, could be identified using a threshold of 80% enhancement (sensitivity, 76%; specificity, 79%).
Kerwin et al. The MRI characteristics of the aorta and carotid arteries may be associated with elevated serum markers of inflammation, frequently in the absence of a definite atheroma.
Weiss et al. 21) compared the MRI findings with serum markers for systemic inflammation. Double inversion recovery, fast spin-echo images of the common carotid arteries and infrarenal aorta were obtained at 1.5 T, both before and after gadolinium-DTPA, in 52 subjects ≥40 years of age. Twentytwo study participants had increases in wall thicknesses (n= 14), T2-weighted signal intensities (n=11) and/or contrast enhancement values (n=7) >2 standard deviations of the control group mean values. Ten subjects in this group had evidence of focal plaques in the carotids (n=5) and/or aorta (n=6). Compared with the remaining 30 subjects, these 22
had significantly higher levels of interleukin-6, C-reactive protein, vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, but no significant differences in the levels of E-selectin.
Accuracy of MRI plaque imaging
Multispectral MRI can identify the lipid-rich necrotic core in human carotid atherosclerosis in vivo, with high sensitivity and specificity. Yuan et al. 
MRI monitoring of the response after statin therapy
High-resolution carotid MRI can provide useful information on the therapeutic response to lipid-lowering drugs. [22] [23] [24] [25] [26] [27] Measurements of the plaque thickness, area, volume, stenosis degrees and characters of plaque components can be compared before and after medical treatment. The treatment plan can be decided from the initial plaque MRI findings. Vulnerability of the plaques, rather than the degree of stenosis, may count more toward the surgical/interventional treatment of carotid stenosis.
McConnell et al. 22) observed regression of atherosclerosis 12 to 20 months after withdrawal of a cholesterol diet and the progression of the atherosclerosis in rabbits with a con- In our institution, 45 patients with 30-70% sonographic carotid stenosis were treated daily with 20 mg of Simvastatin.
They were followed up for 19±7.5 months. In 7 patients (16%), increased fibrous content or plaque cap thickness on multispectral MRI suggested plaque stabilization. There was significant change in the plaque thickness after medical treatment (4.2 mm±1.0 vs. 3.4 mm±1.3, p<0.001) (unpublished data) (Fig. 6 ).
Coronary artery wall imaging
Contrast arteriography can not directly image plaques.
Noninvasive, high-resolution magnetic resonance has the potential to image coronary plaques. [28] [29] [30] [31] [32] [33] [34] Fayad et al. Recently, clinical 3 T scanners have become available. With higher field strengths, coronary vessel wall imaging is likely to benefit from the remarkable gain in signal-to-noise ratio.
Botnar et al. 34) demonstrated the feasibility of in vivo human high field (3 T) coronary vessel wall imaging, using a freebreathing black blood fast gradient echo technique, with respiratory navigator gating and real-time motion correction.
Contrast agents and molecular MRI approach
Ultrasmall superparamagnetic particles of iron oxide (USPIO; Sinerem, Laboratoire Guerbet, Paris, France) can migrate through the interendothelial junctions and capillary pores, because of the small size of the agent and its long halflife in the blood. Ruehm et al. 35) demonstrated iron uptake in the macrophages embedded in atherosclerotic plaque of hyperlipidemic rabbits using MR angiography 5 days after a USPIO injection. The USPIO contrast agent caused marked signal-to-noise ratio (Fig. 7) . The clinical benefit of this agent is its ability to detect atherosclerotic plaques very early.
Recently, fibrin-targeted paramagnetic lipid-encapsulated perflouro-carbon nanoparticles were introduced. 42) This agent targets fibrin in the thrombi overlying the vulnerable plaque, not the plaque itself. Fibrin clots targeted in vitro with paramagnetic nanoparticles showed highly detectable T1-weighted enhancement. Botnar et al. 43) demonstrated that Gd-DTPAlabeled fibrinogen clots appeared as bright hot spots on the black-blood inversion-recovery TFE sequence. A coronary in-stent thrombus was also visible as high signal intensity on the black-blood inversion-recovery TFE sequence after an intracoronary injection of 60 μmol EP-2104R (EPIX Medical, Inc) over 3 min in swine. In their earlier experiment, Botnar et al., 44) found that fibrin-targeted agent is useful in noninvasive in vivo MRI of acute and subacute thrombosis following a plaque rupture in an animal model of atherosclerosis. In the early stage of coronary thrombosis, thrombi are rich in platelets and fibrin. Therefore, detection of acute coronary thrombosis is feasible with the fibrin-targeted agent.
According to Johansson et al., 45) the ability to visualize clots was highly dependent on the spatial resolution of the images.
An in-plane resolution of at least 0.2×0. 
Multidetecor CT
The recently developed high speed CT technique (multidetector-row CT) provides improved z-direction spatial and (Fig. 8-10 )( Table 2 ). The lipid core of the plaque is easily characterized, with a dark density in the plaque (Fig. 8) .
CT detection and measurement of coronary artery calcium
Without injection of a contrast agent, CT clearly visualizes calcifications and coronary calcifications can be quantified. for MDCT and MRI, respectively. There was a significant difference in the CT densities between the two components (p<0.01)( Table 2 ). However, it was difficult to distinguish the lipid-rich from the fibrous areas within the same atherosclerotic lesion on the CT images. According to an ex vivo study, 60) 
